Gavin Clark-Gartner

Stock Analyst at Evercore ISI Group

(2.22)
# 2,843
Out of 5,042 analysts
34
Total ratings
50%
Success rate
-3.04%
Average return

Stocks Rated by Gavin Clark-Gartner

Jasper Therapeutics
Sep 22, 2025
Maintains: Outperform
Price Target: $20$14
Current: $2.37
Upside: +490.72%
AbbVie
Sep 22, 2025
Maintains: Outperform
Price Target: $207$222
Current: $227.99
Upside: -2.63%
Mirum Pharmaceuticals
Aug 8, 2025
Maintains: Outperform
Price Target: $77$89
Current: $70.02
Upside: +27.11%
ProQR Therapeutics
Apr 29, 2025
Initiates: Outperform
Price Target: $5
Current: $2.94
Upside: +70.07%
Mind Medicine (MindMed)
Jan 28, 2025
Initiates: Outperform
Price Target: $23
Current: $12.38
Upside: +85.78%
Cabaletta Bio
Dec 20, 2024
Downgrades: In-Line
Price Target: $15$6
Current: $2.47
Upside: +142.91%
argenx SE
Nov 21, 2024
Maintains: Outperform
Price Target: $675$706
Current: $817.32
Upside: -13.62%
Sarepta Therapeutics
Nov 7, 2024
Maintains: Outperform
Price Target: $179$170
Current: $22.81
Upside: +645.29%
Foghorn Therapeutics
Aug 19, 2024
Initiates: Outperform
Price Target: $20
Current: $4.07
Upside: +391.40%
Krystal Biotech
Aug 12, 2024
Maintains: Outperform
Price Target: $201$206
Current: $186.13
Upside: +10.68%
Initiates: Outperform
Price Target: $22
Current: $2.15
Upside: +923.26%
Maintains: Outperform
Price Target: $20$10
Current: $2.45
Upside: +308.16%
Maintains: Outperform
Price Target: $54$60
Current: $57.29
Upside: +4.73%